论文部分内容阅读
目的观察治疗急性进展性脑卒中的有效方法。方法选择108例急性进展性脑卒中患者随机分为对照组、治疗组各54例,分别给予东菱精纯克栓酶、东菱精纯克栓酶+盐酸丁咯地尔治疗,观察两组治疗前后神经功能缺损程度评分、血流变学及纤维蛋白元变化。结果总有效率,神经功能缺损评分减少,两组比较有显著差异,血液流变学和纤维蛋白元两组治疗前后均下降,两组比较有显著差异。结论盐酸丁咯地尔与东菱精纯克栓酶联合治疗急性进展性脑卒中较单用东菱精纯克栓酶效果好。
Objective To observe the effective treatment of acute progressive stroke. Methods A total of 108 patients with acute progressive stroke were randomly divided into control group and treatment group (n = 54). The patients in each group were given tlinting, The scores of neurological deficits, hemorheology and fibrinogen changes before and after treatment. Results The total effective rate and neurological deficit score decreased. There was a significant difference between the two groups. Hemorheology and fibrinogen both decreased before and after treatment, showing significant differences between the two groups. Conclusion The combination of buflomedil hydrochloride and tazobactam in the treatment of acute progressive stroke is better than tamoxifen alone.